Pages that link to "Q51575070"

The following pages link to Oral bioavailability of trovafloxacin with and without food in healthy volunteers (Q51575070):

Displaying 24 items.

• A critical review of the fluoroquinolones: focus on respiratory infections (Q28215446) (← links)
• Expanded activity and utility of the new fluoroquinolones: a review (Q33544588) (← links)
• Effects of food on clinical pharmacokinetics (Q33747102) (← links)
• Pharmacokinetics and pharmacodynamics of fluoroquinolones (Q33770078) (← links)
• Fluoroquinolones in paediatrics (Q33770091) (← links)
• Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS. (Q33978338) (← links)
• Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin (Q33979388) (← links)
• Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers (Q33980661) (← links)
• The effect of food on the bioavailability of oral gemifloxacin in healthy volunteers (Q34513391) (← links)
• Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin (Q34756641) (← links)
• The new fluoroquinolones: A critical review (Q35649595) (← links)
• Trovafloxacin: a new fluoroquinolone (Q37879173) (← links)
• Trovafloxacin (Q37882192) (← links)
• Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review (Q37982661) (← links)
• The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects (Q42691672) (← links)
• Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers (Q43607263) (← links)
• Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease. Trovafloxacin Surgical Group (Q46253513) (← links)
• In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test. (Q54105197) (← links)
• Overview of quinolones in the treatment and prevention of surgical infection. (Q54106031) (← links)
• Trovafloxacin: An Overview (Q61833702) (← links)
• Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season (Q77583682) (← links)
• Penetration of trovafloxacin into gynecologic tissues (Q77959580) (← links)
• The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects (Q77959586) (← links)
• Effects of food on the pharmacokinetics of sparfloxacin (Q78107386) (← links)